Companion Diagnostics Market to reach a market size of $6.5 billion by 2025
According to a new report Global Companion Diagnostics Market, published by KBV Research, The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.
The Polymerase Chain Reaction (PCR) market dominated the Global Companion Diagnostics Market by Technology in 2018, growing at a CAGR of 20.3% during the forecast period. The Immunohistochemistry market is expected to witness a CAGR of 19.1% during (2019-2025).
The Oncology market dominated the Global Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 21.1 % during the forecast period. The Neurology market is expected to witness a CAGR of 18.3% during (2019-2025).
The North America market dominated the Global Lung Cancer Companion Diagnostics by Region in 2018, growing at a CAGR of 21.7 % during the forecast period. The Europe market is expected to witness a CAGR of 19.9% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 23.5% during (2019-2025).
Full Report: https://www.kbvresearch.com/companion-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.
Global Companion Diagnostics Market Segmentation
By Technology
Immunohistochemistry
Polymerase chain reaction (PCR)
Next generation sequencing (NGS)
In Situ Hybridization and
Other Technology
By Indication
Oncology
Neurology and
Other Indications
By Cancer Type
Breast Cancer
Colorectal Cancer
Lung Cancer
Blood Cancer and
Other Cancer Type
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Australia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
Agilent Technologies, Inc.
Almac Group
ARUP Laboratories, Inc.
Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
Danaher Corporation
Thermo Fisher Scientific, Inc.
Hologic, Inc.
Novartis AG
Illumina, Inc.
Qiagen N.V.
Companion Diagnostics Market Related Reports: